|Day Low/High||97.85 / 98.74|
|52 Wk Low/High||67.04 / 104.78|
Providing more Purchasing Power for Providers at no Additional Cost.
Although equity index futures are lower, this whole thing has been taken in stride. For now.
A partial list of names that are showing signs of breaking out Monday.
The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 1,071,731 share decrease in total short interest for ResMed Inc. , to 6,966,017, a decrease of 13.33% since 10/31/2017.
Managing compliance for sleep apnea patients and increasing resupply revenue just got easier for home medical equipment (HME) providers, as Brightree today announced automated resupply enrollment for patients managed by...
The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 1,305,275 share decrease in total short interest for ResMed Inc. , to 10,131,531, a decrease of 11.41% since 04/13/2017.
Brightree®, the leading provider of cloud-based software for helping post-acute care companies improve business performance and patient outcomes, today announced that its home medical equipment (HME) billing and...
Jim Cramer names a few of his favorite things: housing, bank, material and tech stocks, oil, copper and deregulation.
Jim Cramer takes a closer look at ResMed and its future as a medical-device maker focusing on sleep apnea and COPD.
Short-sellers are feeling the pressure this year, but you don't have to if you take a look at these four stock that could face short squeezes.
The short trade is crowded in these four big stocks.
At CES 2017, SleepScore Labs shared exciting new information that will change the way people think about their sleep.
ResMed (RMD) reported earnings and revenue that fell short of analysts' expectations for the 2017 fiscal first quarter.
Cramer is concerned about Dave & Buster's but says Chipotle's problems are behind it.
When it comes to stock prices, competition has a lot of influence, Cramer says.
Today ResMed welcomed positive results from the independent Home Oxygen Therapy- Home Mechanical Ventilation (HOT-HMV) study 1 regarding the benefits of home non-invasive ventilation (NIV).
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 1,147,291 share increase in total short interest for ResMed Inc. , to 12,554,278, an increase of 10.06% since 07/29/2016.
Jefferies reduced its rating on ResMed (RMD) stock to 'underperform' from 'hold' on Tuesday.
Here are Tuesday's top research calls, including an upgrade for Square and new coverage of Chipotle Mexican Grill, Darden Restaurants and McDonald's.
Trade-Ideas LLC identified ResMed (RMD) as a post-market laggard candidate
Stocks with insider trader activity include MTSI, DXCM and RMD
Trade-Ideas LLC identified ResMed (RMD) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
Trade-Ideas LLC identified ResMed (RMD) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Here are Wednesday's top research calls, including downgrades for Apple, Twitter and Xerox, and an upgrade for JetBlue.
Shares of the maker of sleep-apnea devices are poised to rise and shine.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.